Authors
Latest:
How Useful Are Chargemasters for Price Transparency in Dermatology?Chargemaster lists may encourage patients to shop around for services, but the authors of this report said the implications of this change for dermatology are not well-defined.
Latest:
Advancements in Psoriasis Therapies with Jason Hawkes, MD, MSHawkes highlighted how second-generation TYK2 inhibitors improve upon earlier oral therapies with greater efficacy and selectivity.
Latest:
Breakthrough CRISPR/Cas9 Technique Achieves 95% Exon Deletion for Epidermolysis Bullosa TreatmentA new method using 2 single-guide RNA/Cas9 tools to target 3 specific COL7A1 gene segments with harmful mutations successfully removed up to 95% of those segments.
Latest:
Patch Effective in Extracting Transcriptomes for Precision Medicine in PsoriasisMinimally invasive method outperformed tape stripping in a recent study.
Latest:
Treating Dermatological Conditions by Going Beyond the SkinJodi Westfall, NP, explains how she improves common skin conditions traditionally and from a metabolic perspective.
Latest:
Gaps in Management of AD SOC PatientsDrs Angela Lamb, Omar Noor, and Neal Bhatia share what they consider to be the biggest gaps in care for patients with SOC: patient/provider education, building trust, and appropriate diagnosis of AD.
Latest:
6 Steps to Hiring Great Practice StaffAn expert details the ways to gain and retain new practice staff.
Latest:
Joseph Zabinski, PhD, MEM: Navigating the Future of AI in Skin Cancer DetectionZabinski, vice president and head of commercial strategy and AI at OM1, discusses the evolving role of AI in dermatology, focusing on its potential and challenges in skin cancer detection.
Latest:
Oncodermatology: An Emerging FieldAt the SPDA conference, Meghan Heberton, MD, told attendees about the importance of oncodermatology in patient care.
Latest:
Are AI assistants key to fixing physician burnout?The results of physician trials led by the AAFP Innovation Lab are very promising.
Latest:
Philip Mease, MD, Discusses Head-to-Head BE BOLD Clinical TrialMease, the lead investigator on the trial, spoke about comparing varying mechanisms of action, primary and secondary endpoints, and how the results of BE BOLD could affect treatment choices.
Latest:
Is PR a part of your marketing plan?Ashley Buehnerkemper, director of marketing at VitalSkin Dermatology, discusses what steps you can take to make public relations an active piece of your practice marketing.
Latest:
Quality of Life + Closing ThoughtsMickey Bryson describes the impact of atopic dermatitis on his quality of life and family, and the session concludes with final reflections.
Latest:
Innovative Melanoma Treatment Among NCInnovation's $5.2 Million Research Funding RecipientsMichelle Bolas and Rukiyah T. Van Dross-Anderson, PhD, discuss the significance of NCInnovations’ funding and the clinical impact of Van Dross-Anderson's research in patients with advanced melanoma.
Latest:
Full Pipeline, Customized Diagnoses Expand Options for RosaceaChallenges with overlaps in diagnosis and classification based on rosacea’s 4 subtypes are creating a new focus on features of the condition in each patient. A pipeline of new drugs awaiting FDA approvals could further expand options.
Latest:
Misuse of Ozempic for Rapid Weight Loss Can Cause Significant and Perhaps Permanent Hair LossAmerican Hair Loss Association urges caution.
Latest:
The Science of Atopic Dermatitis With Anna De Benedetto, MDDe Benedetto shares her expertise on new discoveries in the science of atopic dermatitis at RAD 2023.
Latest:
How to get the right fit when hiringExpert tips and techniques on the best ways to select, hire and retain the right people for your team.
Latest:
Abby L. Allen, RN, NP: Update on Biologics for Atopic DermatitisWhat are some of the challenges and triumphs in using biologics for atopic dermatitis? Abby L. Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.
Latest:
What’s New in Hair Loss Therapies and Exosomes?Ronda Farah, MD, FAAD, reviews top hair loss pearls from her 5 sessions at AAD 2024.
Latest:
Chromhidrosis: A Rare Clinical FindingIn rare cases, chromhidrosis may be associated with underlying medical conditions, such as hyperthyroidism, dermatitis herpetiformis, and multiple myeloma.
Latest:
Amber Blair, PA-C, Shares Innovative Insights as SDPA President-ElectRenata Block, MMS, PA-C, and Amber Blair, MMS, PA-C, discuss the gratification of helping patients and the excitement of being on the cutting edge of research.
Latest:
Diversity in Clinical TrialsSusan Taylor, MD, explained the current state of diversity in clinical trials, what is going well, and opportunities to improve.
Latest:
Phase 2 SLEek Clinical Trials Showed Promising Results for Patients With Systemic Lupus ErythematosusJoan Merrill, MD, explained the study's efficacy and safety outcomes and looks forward to phase 3 trials ahead.
Latest:
Other Treatments to Incorporate With JAK InhibitorsRuth Ann Vleugels, MD, MPH, MBA, delves into patient-specific considerations and action plans when on a JAK inhibitor, including shingles prevention and management.
Latest:
SDPA Literature Review Session Shares Clinical PearlsThis special literature review yields a deeper understanding of issues like treating acne, nutraceuticals, and more.
